ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

So what is everyone's guess here? What happens after the K is finally issued?

Here is my guess: The PPS continues to languish until the K is released. Once released, stock bumps up to the .07 - .09 range. Investors will then look for a few decent qtrs of profitability and then it will start to move. Probably won't break .10 till Q1 of next year.

So you are suggesting that the sp will triple simply because a stale 10K with even staler numbers that have already been made public (not to mention are now irrelevant due to the significant changes in operations since then -- most notably the loss of CVS CareMark) will have been issued?

If so, then it would seem that the basis for this is not so much based in numbers or other fundamentals -- but rather, simply on the fact that the act of filing a 10K is in and of itself a major catalyst as it signals to the market that SCRC is alive and still intends to remain compliant with SEC regs? Possible, as down at this .02x level, it actually wouldn't take much to get this to the .07-.09 level...

...but I would actually suggest that as much as I believe that any SEC filing will be hideously hyped, that any pop will be quickly sold down -- simple math tells us that this is how this "catalyst" should be handicapped, for no other reason than the fact that there are approx 7M shares priced in the .02x levels that WILL create resistance at .04x, approx 12M shares priced between .02x-.05x that WILL create resistance by the time the sp reaches the .07x-.08x levels, and almost 20M shares priced between .02x-.06x that WILL create resistance by the time the sp reaches the .09x levels.

Because otherwise the alternative is to look at the numbers fundamentally: Q1 was already PR'd to have net income of only $400k. IF this recurred every quarter for the whole year, we are looking at $1.6M in net earnings. With 140M O/S, this comes out to approx a penny/share in EPS. You would be suggesting that the market is ready to award a multiple of 7-9x simply because a 10K got filed? And keep in mind that this $400k was predominantly all earned PRIOR to the loss of CVS CareMark. But we know that even this scenario is not likely because...

...based on the recent PR, Q2 approved orders was only $5.7M. If Q1 approved orders was $8.7M, then this means Q2 was only 65% of Q1. So a reasonable surrogate to estimate Q2 earnings is to take 65% of Q1's $400k worth of earnings. This gives us Q2 earnings of approx $260k.

Now for Q3, we can estimate approved orders to be $3.3M based upon the $2.2M over the MAY-JUN periods that was also recently PR'd. So again, if $3.3M is 58% of Q2's $5.7M worth of approved orders, then Q3 net earnings can be estimated to be 58% of Q2's $262k, which is approx $150k.

We can also estimate Q4 to be the same as Q3.

So, this gives us $400k (Q1), $260k (Q2), $150k (Q3), and $150k (Q4). Add 'em all up and we get approx $960k in annual net earnings. Divide this thru 140M O/S and you get .0069 EPS. You would need the market to award a multiple of 10x just to get to 6.9 cents/share and 15x to get to 10 cents/share.

So clearly, barring some unexpected fantastic news in the disclosures or MD&A section of the 10K, fundamentals would not justify a sp anywhere near .07-.09.

Doesn't mean that the sp won't get there -- after all, we are in pennyland where hype and promotion can take any stock soaring -- but the money will continue to be made by trading this stock and NOT by buying/adding/holding the way the criminal homophobe JOSEPH ZAMPETTI and the rest of his criminal CORE have and continue to encourage suckers to do. There will be plenty of time to settle into a long-term "hold" position, but that time is ONLY after the risk factors have been reasonably mitigated and the potential REALISTIC rewards become tangibly identifiable.

GLTA...